Equity
€59,745 ▲ 23.2%
DEKARAMA has made a profit in every financial year since 2019.
DEKARAMA
Lifetime
7 annual accounts with figures on one time axispeak €36,919 (2025)
€36,919▲ 18.4%
peak €12,084 (2020)
€11,250▲ 69.1%
peak €59,745 (2025)
€59,745▲ 23.2%
€36,753▼ 19.2%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
30-08-202630 days late
2025micro format
Gross margin from €31,180 to €36,919Result from €6,654 to €11,250Equity from €48,495 to €59,745Debts from €45,473 to €36,753Cash from €11,409 to €28,335
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as DEKARAMA has now. Each dot stands for 68 companies, two years later.
94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for DEKARAMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director
- 16 sharesdeed of 21-12-2018
- 170 sharesdeed of 21-12-2018
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0715975311
2 managers resigning, 2 directors reappointed
Resignations: (manager) and (manager) · Reappointments: (director) and (director) · “Onderneming voor paramedische activiteiten en thuisverpleging,exclusief kinesitherapeuten; Overige…” (deed in Dutch) · General meeting of 09-05-2023 · Gazette deed
Incorporation
Founding capital of €18,600, 186 shares, €6,200 paid up · Founders: and · Appointments: (manager) and (manager) · published on 21-12-2018 · Gazette deed
First establishment
CAM.RA.MAN, Keirselaarstraat 34, Ingelmunster
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DEKARAMA Ingelmunster | €96,498 | €36,919 | 61.9% | - |
| Allô Soins Infi Court-Saint-Etienne | €106,399 | €36,894 | 38.4% | - |
| GONTHIER MELANIE INFIRMIERE Beauraing | €86,425 | €38,980 | 84.8% | - |
| Thuisverpleging Isabeau Geerts Laakdal | €101,401 | €34,238 | 75.2% | - |
| INFILISA Doische | €103,467 | €43,898 | 35.8% | - |
| VANOBAB Ardooie | €83,773 | €43,430 | 20.4% | - |
| Bart Van De Caveye Izegem | €105,031 | €35,796 | 62.1% | - |
These companies have the same main activity as DEKARAMA: nursing and midwifery (NACE 86940). They are comparable in size and age: total assets between €83,800 and €106,000, founded between 2017 and 2020.
Official details
Source: KBO- Status
- Active since 18-12-2018Normal situation
- Activity
- Nursing and midwiferyNACE 86940and 1 other
- Establishment unit
- 2.283.045.8448770 Ingelmunster, since 18-12-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 28-12-2025
Insights on DEKARAMA
DEKARAMA files the micro format. That format states no turnover. The gross margin rose from €9,653 in 2019 to €36,919 in 2025.
The balance sheet grew most from 2020 to 2021 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DEKARAMA
- What is the company number of DEKARAMA?
- The company number of DEKARAMA is 0715.975.311. The VAT number is the same number with BE in front: BE 0715.975.311.
- Where is DEKARAMA based?
- The registered office is at Keirselaarstraat 34, 8770 Ingelmunster.Company details
- What does DEKARAMA do?
- According to the KBO register, the main activity is nursing and midwifery (NACE 86940).
- What is the legal form of DEKARAMA?
- DEKARAMA is a private limited company (BV).
- When was DEKARAMA founded?
- DEKARAMA was founded on 18-12-2018.
- Is DEKARAMA still active?
- Yes, DEKARAMA is an active enterprise in the KBO register.
- What is the turnover of DEKARAMA?
- The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €36,919 and 34 comparable companies (NACE 869). It probably lies between €85,000 and €160,000.Financials
- Is DEKARAMA profitable?
- In financial year 2025, DEKARAMA made a profit of €11,250.
- Where can I find the annual accounts of DEKARAMA?
- DEKARAMA filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DEKARAMA due?
- DEKARAMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.